injectionScientists at the Imperial College London believe they may have found a safer and more effective way of stimulating ovulation in women who are undergoing in-vitro fertilization (IVF).

Typically doctors use a hormone called hCG to help make women’s eggs mature. But just recently, scientists have found that another hormone, Kisspeptin, may be a more effective and natural trigger for egg maturation during IVF treatment.

Their study consisted of 53 healthy women who were given a single injection of the naturally occurring hormone Kisspeptin to induce ovulation. Fifty one of the 53 women developed mature eggs, and 49 of those women had one or two fertilized embryos transferred to the uterus. Ultimately, from the study, 12 healthy babies were born.

This is a major discovery, as one of the main issues with hCG is that it has the potential to cause Ovarian hyperstimulation syndrome (OHSS) which can possibly turn into a major medical problem for some women. Since Kisspeptin breaks down in the body faster than hCG, it decreases the risk of overstimulation.

In order to further investigate, scientists will be conducting more studies on Kisspeptin’s ability to reduce the risk of OHSS and to also learn more about its potential to improve the safety of IVF

To learn more about the study, click here.

The ART Fertility Program of Alabama is located in Birmingham, Alabama with additional locations in Huntsville, Montgomery and Tuscaloosa. The program is led by Dr. Kathryn Honea, Dr. Virginia Houserman and Dr. Chris Allemand who are Board Certified specialists in Reproductive Endocrinology and Infertility. All are skilled in comprehensive infertility care and offer a complete range of infertility services.

Leave a Reply